合成生物学プラットフォーム市場：オファリング、アプリケーション、エンドユーザー別-2025-2030年の世界予測

合成生物学プラットフォーム市場は、2024年には41億1,000万米ドルとなり、2025年には50億4,000万米ドル、CAGR22.81%で成長し、2030年には141億米ドルに達すると予測されています。

合成生物学プラットフォームは、バイオテクノロジー研究と産業応用における画期的なフロンティアです。近年、生物学と工学の融合は、遺伝子操作に関する我々の理解を一変させ、生物システムを合成、改変、利用する前例のない機会を提供しています。本レポートでは、精密性、拡張性、システム革新に重点を置き、急速に発展している合成生物学の分野について考察します。

新たな動向は、疾病治療、オーダーメイド治療薬、持続可能な工業プロセスといった複雑な課題に取り組む上で、こうしたプラットフォームが果たす重要な役割を浮き彫りにしています。研究者や業界の専門家たちは、可能性の限界を押し広げようとたゆまぬ努力を続けており、救命薬から先進的な農業投入物まで、さまざまな製品の設計・生産方法を再構築しています。

学術研究と商業開発の相互作用が強まるにつれ、利害関係者は技術的能力の著しい変容を目の当たりにしています。高度なデータ解析とハイスループットスクリーニング手法の統合は、効率的な製品開発と合理化された業務ワークフローに新たな可能性をもたらしています。本レポートでは、この革命的なセクターを動かしている重要な要素を詳細に調査し、意思決定者や業界の専門家にとって不可欠な洞察を提供します。

合成生物学イノベーションを形成する変革的変化

合成生物学を取り巻く環境はここ数年で大きく変化しました。加速度的な技術の進歩は、研究手法を再定義し、生物学的システムの操作やプログラミングを容易にしました。研究者は現在、洗練された遺伝子編集技術と自動化されたプラットフォームを活用し、従来の手法から高精度の合成生物学アプリケーションへのシームレスな移行を可能にしています。

バイオテクノロジーのインフラへの多大な投資により、より迅速なプロトタイピングと拡張性の向上が可能になりました。この進化は単なる漸進的なものではなく、新たなビジネスモデルを支え、イノベーションの速度を加速させるパラダイムシフトを意味します。デジタル技術、工学、生物学など、セクターを超えた学際的なコラボレーションを重視することで、この産業の成長軌道はさらに豊かになっています。

企業は現在、人工知能と生物学的洞察を組み合わせた統合的アプローチをこれまで以上に実施できるようになり、新たな治療標的の発見や革新的な商業製品の開発につながっています。こうした開発により、官民双方の関心が高まり、共同研究、オープンソースプラットフォーム、安全性と迅速な市場参入の両方を保証する機動的な規制枠組みによって推進されるエコシステムが形成されつつあります。

市場機会を狙うための主要セグメンテーション洞察

市場を注意深く調査すると、合成生物学プラットフォームの多機能性を際立たせる、差別化されたセグメントが見えてくる。DNAシーケンス、DNA合成、mRNA合成などの分野があり、それぞれがカスタマイズされた遺伝子操作や診断精度に独自に貢献しています。同様に重要なのは、アプリケーションに基づくセグメンテーションで、次世代シークエンシング（NGS）と組み合わせた抗体探索、細胞・遺伝子治療の画期的な進歩、進化するワクチン開発の領域など、いずれも専門的なアプローチと最先端の技術を必要とする領域で、イノベーションが進歩を牽引しています。

さらに、エンドユーザーに基づくセグメンテーションは、多様な業界におけるこれらのプラットフォームの展開に関する豊富な洞察を提供します。農業産業などの市場では、遺伝子組み換え作物や収量向上の恩恵があり、一方、飲食品産業では、製品の安全性や栄養成分を高めるために生物学的イノベーションが活用されています。一方、製薬・ライフサイエンス業界は、合成生物学を利用して創薬や薬剤開発のプロトコルに革命をもたらしています。

これらのセグメントは、合成生物学市場のビジネスチャンスの幅広さを示すだけでなく、利害関係者の多様な用途や戦略的優先順位を反映しています。こうしたニュアンスを理解することは、研究戦略と商業投資戦略の双方を整合させ、この変革的産業の可能性を最大限に活用するために不可欠です。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • パーソナライズ医療とカスタマイズされたヘルスケアソリューションの採用が拡大する傾向
    • 合成経路設計を支援するバイオインフォマティクスと計算ツールの拡張
  • 抑制要因
    • 研究開発費の高さと互換性の問題
  • 機会
    • ヘルスケアと農業における効果的なソリューションに対する世界のニーズが合成生物学を後押し
    • 合成生物学を活用して従来のプラスチックに代わる生分解性の代替品を開発
  • 課題
    • 合成生物学の革新におけるサイバーセキュリティの脅威との戦いとデータの完全性の確保の課題
• 市場セグメンテーション分析
  • 提供内容：mRNAワクチン革命によって活性化された進化するmRNA合成
  • エンドユーザー：製薬およびライフサイエンス業界全体で合成生物学プラットフォームの利用を拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 合成生物学プラットフォーム市場：提供別

• DNA配列解析
• DNA合成
• mRNA合成

第7章 合成生物学プラットフォーム市場：用途別

• 抗体の発見とNGS
• 細胞・遺伝子治療
• ワクチン開発

第8章 合成生物学プラットフォーム市場：エンドユーザー別

• 農業産業
• 飲食品業界
• 製薬・ライフサイエンス業界

第9章 南北アメリカの合成生物学プラットフォーム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の合成生物学プラットフォーム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの合成生物学プラットフォーム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• American Institute of Chemical Engineers
• Amyris, Inc.
• Antheia, Inc.
• Arbor Biosciences
• Codexis, Inc.
• CSIRO
• DNA Script
• ElevateBio, LLC
• Engineering Biology Research Center
• Genetic Engineering & Biotechnology
• Genomatica, Inc.
• Genome Canada
• Ginkgo Bioworks, Inc.
• Gniubiotics
• Harvard Medical School
• Illumina Inc
• Integrated DNA Technologies, Inc.
• LanzaTech
• Mammoth Biosciences, Inc.
• New England Biolabs
• Sojitz Corporation
• Synbio Technologies
• Twist Bioscience Corporation
• Zymergen Inc.

LIST OF FIGURES

• FIGURE 1. SYNTHETIC BIOLOGY PLATFORMS MARKET MULTI-CURRENCY
• FIGURE 2. SYNTHETIC BIOLOGY PLATFORMS MARKET MULTI-LANGUAGE
• FIGURE 3. SYNTHETIC BIOLOGY PLATFORMS MARKET RESEARCH PROCESS
• FIGURE 4. SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 15. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 17. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. SYNTHETIC BIOLOGY PLATFORMS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 23. SYNTHETIC BIOLOGY PLATFORMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. SYNTHETIC BIOLOGY PLATFORMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SYNTHETIC BIOLOGY PLATFORMS MARKET DYNAMICS
• TABLE 7. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY MRNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY ANTIBODY DISCOVERY & NGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY AGRICULTURE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY FOOD & BEVERAGE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 30. CANADA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 47. CHINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 50. INDIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 102. ITALY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 114. POLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 117. QATAR SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. SYNTHETIC BIOLOGY PLATFORMS MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 147. SYNTHETIC BIOLOGY PLATFORMS MARKET, FPNV POSITIONING MATRIX, 2024

The Synthetic Biology Platforms Market was valued at USD 4.11 billion in 2024 and is projected to grow to USD 5.04 billion in 2025, with a CAGR of 22.81%, reaching USD 14.10 billion by 2030.

Synthetic biology platforms represent a groundbreaking frontier in biotechnological research and industrial application. In recent times, the fusion of biology and engineering has revolutionized our understanding of genetic manipulation, offering unprecedented opportunities to synthesize, modify, and harness biological systems. This report examines the rapidly evolving field of synthetic biology, characterized by its emphasis on precision, scalability, and systemic innovation.

Emerging trends have highlighted the critical role of these platforms in addressing complex challenges such as disease treatment, customized therapeutics, and sustainable industrial processes. Researchers and industry experts are tirelessly working to push the boundaries of what is possible, reshaping how products ranging from life-saving drugs to advanced agricultural inputs are designed and produced.

As the interplay between academic research and commercial development intensifies, stakeholders are witnessing a significant transformation in technological capabilities. The integration of advanced data analytics and high-throughput screening methods has unlocked new potential for efficient product development and streamlined operational workflows. This report offers an in-depth exploration of the key elements powering this revolutionary sector, providing essential insights for decision-makers and industry experts alike.

Transformative Shifts Reshaping Synthetic Biology Innovation

The synthetic biology landscape has undergone profound changes over the past few years. Accelerated technological advancements have redefined research methodologies, making it easier to manipulate and program biological systems. Researchers now leverage sophisticated genetic editing techniques and automated platforms, allowing for a seamless transition from traditional methods to high-precision synthetic biology applications.

Significant investments in biotechnology infrastructure have enabled faster prototyping and improved scalability. This evolution is not merely incremental but represents a paradigm shift that underpins new business models and accelerates the rate of innovation. Emphasis on interdisciplinary collaboration across sectors, including digital technology, engineering, and biology, has further enriched the growth trajectory of this industry.

Companies are now more capable than ever of undertaking integrated approaches that combine artificial intelligence with biological insights, leading to the discovery of novel therapeutic targets and innovative commercial products. These developments have spurred a surge in both public and private sector interest, culminating in an ecosystem driven by collaborative research, open-source platforms, and agile regulatory frameworks that ensure both safety and rapid market entry.

Key Segmentation Insights for Targeting Market Opportunities

A careful examination of the market reveals differentiated segments that highlight the multifunctional nature of synthetic biology platforms. One clear dimension stems from the offerings available, which include areas such as DNA Sequencing, DNA Synthesis, and mRNA Synthesis, each contributing uniquely to customized gene manipulation and diagnostic precision. Equally important is the segmentation based on application where innovations drive advancements across Antibody Discovery combined with next-generation sequencing (NGS), Cell and Gene Therapy breakthroughs, and the evolving domain of Vaccine Development, all of which demand specialized approaches and leading-edge technologies.

In addition, the segmentation based on end users offers rich insights into the deployment of these platforms across diverse industries. Markets such as the Agriculture Industry benefit from engineered crops and improved yields, whereas the Food & Beverage Industry leverages biological innovations to enhance product safety and nutritional content. The Pharmaceutical & Life Science Industry, meanwhile, uses synthetic biology to revolutionize drug discovery and development protocols.

Together, these segments not only illustrate the range of opportunities within the synthetic biology market but also reflect the diverse applications and strategic priorities of stakeholders. Understanding these nuances is essential for aligning both research and commercial investment strategies to harness the full potential of this transformative industry.

Based on Offering, market is studied across DNA Sequencing, DNA Synthesis, and mRNA Synthesis.

Based on Application, market is studied across Antibody Discovery & NGS, Cell & Gene Therapy, and Vaccine Development.

Based on End User, market is studied across Agriculture Industry, Food & Beverage Industry, and Pharmaceutical & Life Science Industry.

Regional Insights Driving Global Synthetic Biology Dynamics

The synthetic biology market exhibits significant regional variation driven by local innovation ecosystems and policy frameworks. In the Americas, robust funding mechanisms and close collaboration between academic institutions and industry have propelled breakthroughs in genetic engineering and bio-manufacturing. The region offers a fertile ground for rapid product development, supported by a strong intellectual property environment and a well-established biotech industry.

Across Europe, the Middle East and Africa, regulatory harmonization and strategic public investments have fostered a conducive environment for pioneering research in synthetic biology. This region is characterized by an emphasis on sustainability and green technologies, which has encouraged the integration of synthetic biology in environmental management and resource optimization strategies.

The Asia-Pacific region has emerged as a dynamic hub with a burgeoning biotechnology sector, supported by governmental incentives and substantial investments in research infrastructure. Rapid industrialization, coupled with a growing focus on health and agriculture, has spurred innovative applications that promise significant economic and social impact. Each of these regions offers unique strengths that contribute to the global tapestry of synthetic biology advancements.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Shaping the Synthetic Biology Ecosystem

The market is witnessing the formidable influence of a diverse array of companies that are setting benchmarks in technology, research, and commercial innovation. Key players include Agilent Technologies, Inc. and American Institute of Chemical Engineers, which bring decades of expertise and innovation to the domain. Firms like Amyris, Inc. and Antheia, Inc. are known for their pioneering work in metabolic engineering and novel biochemical production.

Organizations such as Arbor Biosciences and Codexis, Inc. have emphasized the importance of customized solutions in genetic editing and synthetic enzyme development, while CSIRO and DNA Script provide cutting-edge tools that consistently push the boundaries of gene synthesis. ElevateBio, LLC and Engineering Biology Research Center contribute significantly to streamlined research and translational applications.

Additional organizations including Genetic Engineering & Biotechnology and Genomatica, Inc. stand out for their forward-thinking approaches to sustainable production. Research institutions like Genome Canada and Harvard Medical School support essential academic advancements, and companies such as Ginkgo Bioworks, Inc., Integrated DNA Technologies, Inc., and Illumina Inc. ensure that innovative synthesis methods and sequencing technologies remain at the forefront of industry development. Firms like LanzaTech, Mammoth Biosciences, Inc., and New England Biolabs contribute through transformative process optimizations. Strategic players such as Sojitz Corporation, Synbio Technologies, Twist Bioscience Corporation, and Zymergen Inc. complete this diverse landscape of innovators who are redefining the possibilities of synthetic biology.

The report delves into recent significant developments in the Synthetic Biology Platforms Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., American Institute of Chemical Engineers, Amyris, Inc., Antheia, Inc., Arbor Biosciences, Codexis, Inc., CSIRO, DNA Script, ElevateBio, LLC, Engineering Biology Research Center, Genetic Engineering & Biotechnology, Genomatica, Inc., Genome Canada, Ginkgo Bioworks, Inc., Gniubiotics, Harvard Medical School, Illumina Inc, Integrated DNA Technologies, Inc., LanzaTech, Mammoth Biosciences, Inc., New England Biolabs, Sojitz Corporation, Synbio Technologies, Twist Bioscience Corporation, and Zymergen Inc.. Actionable Recommendations for Thriving in the Synthetic Biology Sector

Industry leaders must adapt to the rapidly changing ecosystem by embracing integrated innovation strategies and forward-thinking policies. It is essential to invest in research and development that fosters cross-disciplinary collaboration, leveraging expertise from bioinformatics, data analytics, and molecular biology to drive breakthrough discoveries. Leaders should consider expanding partnerships with academic institutions and technology firms to share knowledge and reduce time-to-market for new applications.

Furthermore, companies are encouraged to prioritize flexible manufacturing processes and scalability. Emphasizing automation and utilizing high-throughput screening technologies can streamline production workflows and enhance operational efficiency. Concurrently, ensuring compliance with evolving regulatory standards will be crucial for long-term success in this complex marketplace.

It is also advised that organizations pursue market diversification by extending their focus beyond core therapeutic applications. Enhancing engagement with emerging segments such as agricultural innovations, food safety enhancements, and environmental sustainability initiatives can open new streams of revenue. Continuous monitoring of regional market dynamics and investment in cutting-edge project pilots can serve as powerful levers to secure competitive advantage. Ultimately, actionable collaboration along with proactive adoption of emerging technologies will be the cornerstone for sustained leadership in the synthetic biology arena.

Synthesizing Conclusions and Insights for a Progressive Future

The synthetic biology sector is clearly at a pivotal junction, marked by rapid technological evolution and robust market expansion. Our analysis has shown that while the industry presents complex challenges, it also opens up vast opportunities for innovation, economic growth, and societal benefits. The convergence of advanced genetic tools, automation, and data-driven methodologies has enabled the creation of novel biological solutions that are reshaping therapeutic, agricultural, and industrial paradigms.

As leaders navigate this dynamic landscape, it is crucial to appreciate the interdependencies across segments, regions, and corporate actors. A holistic understanding of market segmentation - spanning offerings, applications, and end-user criteria - equips stakeholders with the insights needed to make informed, strategic decisions. The competitive environment, bolstered by key companies with diverse capabilities, underscores the importance of fostering continuous innovation and strategic collaboration.

In summary, a forward-looking approach that integrates technological advancements, regional strengths, and diversified market strategies will enable industry players to harness the full potential of synthetic biology. The future promises significant returns on investments made in research and technology with a proactive adaptation to global standards and trends.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. General trend towards personalized medicine and tailored healthcare solutions growing adoption
    • 5.1.1.2. Expansion of bioinformatics and computational tools aiding in synthetic pathway design
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of research and development and compatibility issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Global need for effective solutions in healthcare and agriculture fueling synthetic biology
    • 5.1.3.2. Harnessing synthetic biology to create biodegradable alternatives to traditional plastics
  • 5.1.4. Challenges
    • 5.1.4.1. Challenges in combating cybersecurity threats and ensuring data integrity in synthetic biology innovations
• 5.2. Market Segmentation Analysis
  • 5.2.1. Offering: Evolving mRNA synthesis invigorated by the mRNA vaccine revolution
  • 5.2.2. End User: Expanding usage of the synthetic-biology-platforms across the pharmaceutical & life science industry

• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Synthetic Biology Platforms Market, by Offering

• 6.1. Introduction
• 6.2. DNA Sequencing
• 6.3. DNA Synthesis
• 6.4. mRNA Synthesis

7. Synthetic Biology Platforms Market, by Application

• 7.1. Introduction
• 7.2. Antibody Discovery & NGS
• 7.3. Cell & Gene Therapy
• 7.4. Vaccine Development

8. Synthetic Biology Platforms Market, by End User

• 8.1. Introduction
• 8.2. Agriculture Industry
• 8.3. Food & Beverage Industry
• 8.4. Pharmaceutical & Life Science Industry

9. Americas Synthetic Biology Platforms Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Synthetic Biology Platforms Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Synthetic Biology Platforms Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2024
• 12.2. FPNV Positioning Matrix, 2024
• 12.3. Competitive Scenario Analysis
  • 12.3.1. LVMH Recherche and Integrated Biosciences to enhance anti-aging skincare using AI and synthetic biology platforms
  • 12.3.2. Ansa Biotechnologies advances DNA synthesis with new assembly technology
  • 12.3.3. Researchers at Yale developed a generative AI platform for synthetic DNA sequences
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. American Institute of Chemical Engineers
• 3. Amyris, Inc.
• 4. Antheia, Inc.
• 5. Arbor Biosciences
• 6. Codexis, Inc.
• 7. CSIRO
• 8. DNA Script
• 9. ElevateBio, LLC
• 10. Engineering Biology Research Center
• 11. Genetic Engineering & Biotechnology
• 12. Genomatica, Inc.
• 13. Genome Canada
• 14. Ginkgo Bioworks, Inc.
• 15. Gniubiotics
• 16. Harvard Medical School
• 17. Illumina Inc
• 18. Integrated DNA Technologies, Inc.
• 19. LanzaTech
• 20. Mammoth Biosciences, Inc.
• 21. New England Biolabs
• 22. Sojitz Corporation
• 23. Synbio Technologies
• 24. Twist Bioscience Corporation
• 25. Zymergen Inc.